WP Advisors LLC Decreases Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

WP Advisors LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 15.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,613 shares of the exchange traded fund’s stock after selling 479 shares during the quarter. WP Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $235,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. FMR LLC boosted its position in SPDR S&P Biotech ETF by 13.6% during the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after purchasing an additional 830 shares in the last quarter. Ameritas Advisory Services LLC boosted its position in SPDR S&P Biotech ETF by 11.9% during the fourth quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after purchasing an additional 1,137 shares in the last quarter. Beaton Management Co. Inc. purchased a new stake in SPDR S&P Biotech ETF during the third quarter worth $212,000. Hollow Brook Wealth Management LLC lifted its position in shares of SPDR S&P Biotech ETF by 4.9% in the third quarter. Hollow Brook Wealth Management LLC now owns 21,669 shares of the exchange traded fund’s stock valued at $2,141,000 after acquiring an additional 1,003 shares in the last quarter. Finally, Private Advisor Group LLC lifted its position in shares of SPDR S&P Biotech ETF by 0.7% in the third quarter. Private Advisor Group LLC now owns 224,845 shares of the exchange traded fund’s stock valued at $22,215,000 after acquiring an additional 1,530 shares in the last quarter.

SPDR S&P Biotech ETF Stock Up 0.2 %

Shares of NYSEARCA:XBI opened at $92.72 on Friday. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The stock’s fifty day simple moving average is $91.39 and its 200-day simple moving average is $95.98. The company has a market capitalization of $7.07 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.